Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

15.73USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$15.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
230,959
52-wk High
$35.99
52-wk Low
$15.49

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $693.84
Shares Outstanding(Mil.): 43.42
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.16 -- --
ROI: -34.79 0.60 13.80
ROE: -41.10 -2.18 15.29

Earnings vs. Estimates